Caisse De Depot Et Placement Du Quebec Regeneron Pharmaceuticals, Inc. Transaction History
Caisse De Depot Et Placement Du Quebec
- $45.5 Billion
- Q2 2025
A detailed history of Caisse De Depot Et Placement Du Quebec transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Caisse De Depot Et Placement Du Quebec holds 214,722 shares of REGN stock, worth $124 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
214,722
Previous 222,614
3.55%
Holding current value
$124 Million
Previous $141 Million
20.16%
% of portfolio
0.25%
Previous 0.3%
Shares
32 transactions
Others Institutions Holding REGN
# of Institutions
1,423Shares Held
88.8MCall Options Held
1.98MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.44 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.87 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.26 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.79 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.21 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $61.8B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...